DT
CORT icon

Diversified Trust’s Corcept Therapeutics CORT Stock Holding History

Diversified Trust’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+2,417
New +$146K ﹤0.01% 1036
2024
Q1 		– Sell
-7,656
Closed -$249K – 855
2023
Q4 		$249K Sell
7,656
-1,667
-18% -$45.8K 0.01% 716
2023
Q3 		$254K Buy
+9,323
New +$270K 0.01% 687
2017
Q4 		– Sell
-26,200
Closed -$506K – 308
2017
Q3 		$506K Buy
+26,200
New +$391K 0.04% 158

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversified Trust's CORT Position: Q2 2026 in Review

Diversified Trust opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 2,417 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1036 among its holdings. This is a return to the name: Diversified Trust previously reported a position in CORT as recently as Q4 2023.

Diversified Trust first reported a position in CORT in Q3 2017 and has held it in 4 quarters since. The position peaked at $506K in Q3 2017. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Diversified Trust held 2,417 shares of Corcept Therapeutics worth $210K as of Q2 2026.
  • Corcept Therapeutics was a new Diversified Trust position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #1036 holding.
  • Diversified Trust first reported a position in Corcept Therapeutics in Q3 2017 and has held it in 4 quarters since.
  • Diversified Trust's Corcept Therapeutics position peaked at $506K in Q3 2017.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.